What Does Unicycive Therapeutics Inc.'s 39.1% Stock Drop Mean for Investors? The Law Offices of Howard G. Smith Outline Securities Fraud Class Action Lead Plaintiff Deadline

Summary

The suit alleges Unicycive Therapeutics, Inc. failed to disclose key facts to investors from December 29, 2025 through June 29, 2026; lead plaintiff deadline is November 2, 2026 BENSALEM TOWNSHIP, Pa., Oct. 22, 2026 /PRNe...